Research and Development

 UK biotech ReNeuron has been given the go-ahead for a ground-breaking stem cell clinical trial.The phase I trial of its …

Biotech leaders in the UK say the cash-stricken industry has reached ‘breaking point’, and have made an unprecedented plea for …

Jobs losses at Pfizer's research and development centre in Sandwich, Kent look a certainty after the company announced cutbacks to …

A public-private partnership aiming to determine the three-dimensional structure of medically-relevant proteins and put them in the public domain has …

On a recent trip I made to India, the resourcefulness of the country's people was demonstrated to me as soon …

Cash-stricken UK biotech has been left hanging on for government funding, without any guarantee it will get the support needed. …

Novartis has added an investigational vaccine to its pipeline through a $20 million deal with AlphaVax. The North Carolina-based biotech …

How did you find your way into your role? I wanted to be a chemist from my very first experience …

The credit crunch hits biotechBy October Europe's biotech sector was feeling severe effects from the credit crunch, with small and …

  Patient power proves decisive in battle for accessSocial networking helped a new breed of informed patient advocates win the …

Lilly aims to reduce the cost of it bringing new molecules to market by a third.The company's goal is to …

A number of pharmaceutical companies in the US have recently announced they will declare all the payments to healthcare professionals. …

Biotech leaders in the UK say the cash-stricken industry has reached 'breaking point', and have made an unprecedented plea for …